Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Summary

The purpose of this study is to explore the efficacy and safety of Ciclesonide Nasal Spray 200 microgram (mcg) once daily in the treatment of seasonal allergic rhinitis (SAR) in Russian participants.

Timeline

Start

2014-08

Primary completion

2014-10

Completion

2014-11

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Ciclesonide 200 mcg vs Placebo; p = 0.9716; Mean Difference (Net) 0.02 (95% CI -0.98 to 1.01); ANCOVA NCT02155881 ↗

Drugs

Indications